Moreover, Ogawa et al. [31] demonstrated that angiotensin II receptor blocker (ARB) treatment reduces urinary Alb levels at the stage of microalbuminuria underlying diabetic nephropathy when the urinary oxidative stress marker and AGT are high. Here, ALB is linked to diabetic kidney disease.